Company / Shares Outstanding
Esperion Therapeutics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
207.9M
FY2025
5-year range
27.1M / 207.9M
FY2021-FY2025
Trend
+11.0%
vs FY2024
Sector context
#42 of 212
Health Care
What the data says
Esperion Therapeutics, Inc.'s shares outstanding of 207865080.00 is higher than 80% of companies in the Health Care sector (FY2025). Shares Outstanding has increased for 4 consecutive years, from 27090284.00 in FY2021 to 207865080.00 in FY2025.
Based on SEC 10-K filings.
207865080.00 in FY2025 with a 5-year CAGR of +49.9%. Top quartile in the Health Care sector.
Increased from 103106616.00 to 207865080.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +46.3%
- 5-Year CAGR
- +49.9%
- 10-Year CAGR
- -
Sector benchmark
-32.2% below sector average
Key checks
Key Insights
- Esperion Therapeutics, Inc.'s shares outstanding has grown for 4 consecutive years.
- In FY2025, shares outstanding increased 11.0% year-over-year.
- Ranks #42 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 207.9M | +11.0% |
| FY2024 | 187.2M | +81.5% |
| FY2023 | 103.1M | +55.3% |
| FY2022 | 66.4M | +145.1% |
| FY2021 | 27.1M | -1.5% |
| FY2020 | 27.5M | +2.5% |
| FY2019 | 26.8M | +0.3% |
| FY2018 | 26.8M | +11.8% |
| FY2017 | 23.9M | +6.2% |
| FY2016 | 22.5M | +2.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026